Version June 2024
| Condition | COC | CIC | P/R | POP | DMPA NET-EN | LNG/ETG Implants | Cu-IUD | LNG-IUD |
| Vaginal bleeding patterns | ||||||||
| Irregular pattern without heavy bleeding | 1 | 1 | 1 | 2 | 2 | 2 | 1 | Initiation: 1 |
| Continuation: 1 | ||||||||
| Heavy or prolonged bleeding (includes regular and irregular patterns) | 1 | 1 | 1 | 2 | 2 | 2 | 2 | Initiation: 1 |
| Continuation: 2 | ||||||||
| Unexplained vaginal bleeding (suspicious for serious condition) | ||||||||
| Before evaluation | 2 | 2 | 2 | 2 | 3 | 3 | Initiation: 4 | Initiation: 4 |
| Continuation: 2 | Continuation: 2 | |||||||
| Endometriosis | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Benign ovarian tumors (including cysts) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Severe dysmenorrhoea | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Gestational trophoblastic disease | ||||||||
| Decreasing or undetectable human chorionic gonadotropin levels | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 |
| Persistently elevated human chorionic gonadotropin levels or malignant disease | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 4 |
| Cervical ectropion | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Cervical intraepithelial neoplasia (CIN) | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 2 |
| Cervical cancer (awaiting treatment) | 2 | 2 | 2 | 1 | 2 | 2 | Initiation: 4 | Initiation: 4 |
| Continuation: 2 | Continuation: 2 | |||||||
| Breast disease | ||||||||
| Undiagnosed mass | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| Benign breast disease | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Family history of cancer | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Cancer | ||||||||
| Current | 4 | 4 | 4 | 4 | 4 | 4 | 1 | 4 |
| Past and no evidence of current disease for five years | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 3 |
| Endometrial cancer | 1 | 1 | 1 | 1 | 1 | 1 | Initiation: 4 | Initiation: 4 |
| Continuation: 2 | Continuation: 2 | |||||||
| Ovarian cancer | 1 | 1 | 1 | 1 | 1 | 1 | Initiation: 3 | Initiation: 3 |
| Continuation: 2 | Continuation: 2 | |||||||
| Uterine fibroids | ||||||||
| Without distortion of the uterine cavity | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| With distortion of the uterine cavity | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 4 |
| Anatomical abnormalities | ||||||||
| That distort the uterine cavity | 4 | 4 | ||||||
| That do not distort the uterine cavity | 2 | 2 | ||||||
| Pelvic inflammatory disease (PID) | ||||||||
| Past PID (assuming no current risk factors of STIs) | ||||||||
| With subsequent pregnancy | 1 | 1 | 1 | 1 | 1 | 1 | Initiation: 1 | Initiation: 1 |
| Continuation: 1 | Continuation: 1 | |||||||
| Without subsequent pregnancy | 1 | 1 | 1 | 1 | 1 | 1 | Initiation: 2 | Initiation: 2 |
| Continuation: 2 | Continuation: 2 | |||||||
| PID - current or within last three months | 1 | 1 | 1 | 1 | 1 | 1 | Initiation: 4 | Initiation: 4 |
| Continuation: 2 | Continuation: 2 | |||||||
| STIs (sexually transmitted infections) | ||||||||
| Current purulent cervicitis or chlamydial infection or gonorrhoea | 1 | 1 | 1 | 1 | 1 | 1 | Initiation: 4 | Initiation: 4 |
| Continuation: 2 | Continuation: 2 | |||||||
| Other STIs (excluding HIV and hepatitis) | 1 | 1 | 1 | 1 | 1 | 1 | Initiation: 2 | Initiation: 2 |
| Continuation: 2 | Continuation: 2 | |||||||
| Vaginitis (including trichomonas vaginalis and bacterial vaginosis) | 1 | 1 | 1 | 1 | 1 | 1 | Initiation: 2 | Initiation: 2 |
| Continuation: 2 | Continuation: 2 | |||||||
| Increased risk of STIs | 1 | 1 | 1 | 1 | 1 | 1 | Initiation: 2/3 | Initiation: 2/3 |
| Continuation: 2 | Continuation: 2 | |||||||
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
